Headline
The latest stories from AHA Today.
Applications for the 2026 AHA Rural Hospital Excellence in Innovation Award close Aug. 29 at 1 p.m. ET.
A study published by JAMA Aug. 13 found that a two-dose antibiotic treatment could be just as effective as traditional long-term IV therapy for treating serious Staphylococcus aureus bloodstream infections.
The Texas Department of State Health Services Aug. 18 announced that the state’s measles outbreak is over.
The Centers for Medicare & Medicaid Services Innovation Center Aug. 12 released an FAQ on the Wasteful and Inappropriate Service Reduction Model, a six-year technology-enabled prior authorization program pilot.
The American Heart Association and American College of Cardiology Aug. 14 released new guidelines on high blood pressure prevention, suggesting earlier treatment can reduce the risk of cognitive decline and dementia, as well as cardiovascular disease, stroke and kidney disease.
The Health Resources and Services Administration has awarded more than $15 million in grants to 58 rural health organizations for four-year projects as part of the Federal Office of Rural Health Policy’s Rural Health Care Services Outreach program.
The American Organization for Nursing Leadership Aug, 15 announced that Stuart Downs, DNP, R.N., was elected as the 2026 president-elect of the AONL Board of Directors.
The Cybersecurity and Infrastructure Security Agency, Environmental Protection Agency, National Security Agency, FBI and international agencies Aug. 13 released guidance for operational technology owners and operators to create and manage an OT asset inventory.
The Health Resources and Services Administration is requesting public comments on its recommendation to add metachromatic leukodystrophy and Duchenne muscular dystrophy to the Recommended Uniform Screening Panel. The RUSP is a list of disorders that the Secretary of the Department of Health and…
The Department of Health and Human Services Aug. 14 announced it will reinstate the Task Force on Safer Childhood Vaccines, a federal panel to provide oversight on vaccines for U.S. children.